Ck Life Sciences
Ck Life Sciences, also known as Ck Life Sciences International Holdings, is a prominent biotechnology company headquartered in Hong Kong. Founded in 2000, the company has established itself as a leader in the life sciences sector, focusing on innovative solutions in agricultural biotechnology and healthcare. With a strong presence in Asia and expanding operations globally, Ck Life Sciences is dedicated to developing unique products that enhance crop yields and improve human health. Their core offerings include advanced biopesticides and nutraceuticals, distinguished by their commitment to sustainability and efficacy. Recognised for its pioneering research and development, Ck Life Sciences has achieved significant milestones, positioning itself as a key player in the biotechnology industry. The company continues to drive advancements that contribute to a healthier and more sustainable future.
DitchCarbon Score
How does Ck Life Sciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ck Life Sciences's score of 39 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ck Life Sciences's reported carbon emissions
In 2024, Ck Life Sciences reported total carbon emissions of approximately 47,495,000 kg CO2e, comprising about 31,245,000 kg CO2e from Scope 1 and about 16,250,000 kg CO2e from Scope 2 emissions. This marks a slight increase from 2023, where total emissions were about 48,960,000 kg CO2e, with Scope 1 emissions at approximately 32,037,000 kg CO2e and Scope 2 emissions at about 16,923,000 kg CO2e. Ck Life Sciences has set a long-term commitment to achieve net-zero emissions by 2050, aligning with the NGFS Net Zero 2050 framework. This commitment encompasses all scopes of emissions, reflecting the company's dedication to addressing its carbon footprint comprehensively. The company has consistently disclosed its emissions data for Scope 1 and Scope 2, but has not reported on Scope 3 emissions. Over the past few years, Ck Life Sciences has demonstrated a proactive approach to sustainability, focusing on reducing its greenhouse gas emissions intensity relative to revenue, which was approximately 0.000011 for Scope 1 and 2 in 2023. Overall, Ck Life Sciences is actively working towards its climate commitments while monitoring and reporting its emissions transparently from its headquarters in Hong Kong.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 28,483,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 16,100,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ck Life Sciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
